Report cover image

Blood Glucose Monitor Market by Product Type (Self blood glucose monitoring, Professional point of care), Application (Diabetes management, Health & Wellness Monitoring), Test site (Fingertip, Upper arm), End User (Self/Homecare) - Global Forecast to 2030

Publisher MarketsandMarkets
Published Nov 21, 2025
Length 302 Pages
SKU # MKMK20610471

Description

The global blood glucose monitor market is projected to reach 25.4 billion in 2030 from USD 16.5 billion in 2025, at a CAGR of 9.1% during the forecast period.

The market for blood glucose monitors is expected to grow strongly, driven by demographic, clinical, and technological factors. The rising global prevalence of diabetes, coupled with an expanding geriatric population and increasing awareness of self-monitoring, continues to fuel demand for blood glucose monitoring devices. Technological advancements, including continuous glucose monitoring (CGM), integration with smartphones and wearables, and AI-based data analytics, have significantly improved accuracy, convenience, and patient engagement, thereby accelerating adoption. Furthermore, supportive government initiatives, improved healthcare infrastructure, and expanding access to home-based monitoring solutions are contributing to market growth. These trends are expected to sustain robust momentum across both developed and emerging economies in the coming years.

Based on product type, the self-monitoring blood glucose systems segment accounted for the largest share in the blood glucose monitor market in 2024.

Based on product type, the global blood glucose monitor market is divided into four main segments: self-monitoring blood glucose systems, continuous glucose monitoring systems, professional point-of-care devices, and non-invasive products. Among these, self-monitoring blood glucose (SMBG) systems have gained the highest adoption due to their optimal balance between accuracy, comfort, and convenience for patients, particularly those managing their condition at home. These devices offer quick and reliable glucose readings with minimal discomfort, encouraging consistent self-monitoring practices. Additionally, advancements such as micro-needle lancets, smaller sample requirements, and improved test strip designs have enhanced their usability. Their compatibility with connected health ecosystems—including smartphone apps, cloud-based data tracking, and telehealth integration—further drives patient engagement and improves healthcare provider oversight. Growing patient preference for affordable, easy-to-use monitoring tools, combined with rising awareness of proactive diabetes management, continues to reinforce the dominance of the SMBG segment across both developed and developing markets.

Based on application, the diabetes management segment is expected to grow at the highest CAGR during the forecast period in the blood glucose monitor market.

The global blood glucose monitor market is segmented by application into three categories: diabetes management, health & wellness monitoring, and other applications. Among these, the diabetes management segment is projected to witness the fastest growth during the forecast period, driven by the rising prevalence of type 1 and type 2 diabetes and the growing need for continuous and precise glucose tracking. The increasing adoption of continuous glucose monitoring (CGM) systems, which offer real-time insights, has enabled improved insulin dosing, dietary management, and lifestyle optimization. The integration of monitoring devices with digital health platforms, mobile applications, and cloud-based analytics enables remote consultations, automated alerts, and seamless data sharing with healthcare professionals, thereby supporting personalized diabetes care. Moreover, the growing emphasis on preventive healthcare, early disease detection, and supportive reimbursement programs is encouraging the adoption of regular monitoring. The availability of compact, user-friendly, and connected home monitoring devices empowers patients to independently manage their glucose levels, ensuring better compliance and reducing the risk of severe complications. Additionally, the rising consumer focus on health optimization and metabolic wellness is expanding the use of glucose monitors beyond traditional diabetes management, further amplifying market growth.

North America is expected to register the highest share of the blood glucose monitor market during the forecast period.

The global blood glucose monitor market is divided into six main regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and the GCC Countries.

North America accounted for the largest share of the global blood glucose monitor market, driven by its advanced healthcare infrastructure, high diabetes prevalence, and strong adoption of digital health technologies. The region benefits from the widespread availability of continuous glucose monitoring (CGM) systems, favorable reimbursement frameworks, and increased awareness of diabetes management and preventive care. Moreover, the strong presence of leading market players, continuous product innovation, and strategic collaborations between healthcare providers and technology companies further reinforce North America’s leadership position. Rising healthcare expenditure, growing geriatric population, and the rapid integration of connected and AI-enabled glucose monitoring devices continue to support sustained market growth across the region.



A breakdown of the primary participants (supply side) for the blood glucose monitor market referred to in this report is provided below:
  • By Company Type: Tier 1 (30%), Tier 2 (35%), and Tier 3 (35%)
  • By Designation: C-level Executives (20%), Directors (35%), and Others (45%)
  • By Region: North America (30%), Europe (25%), Asia Pacific (20%), Latin America (20%), Middle East & Africa (2%), GCC Countries (3%)
Prominent players in the blood glucose monitor market include Abbott Laboratories (US), Dexcom, Inc. (US), Medtronic (Ireland), B.Braun SE (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Ascensia Diabetes Care Holdings AG (Switzerland), Senseonics (US), Nipro (Japan), Medical Technology and Devices S.p.A. (Italy), Terumo Corporation (Japan), i-SENS, Inc. (South Korea), Sinocare (China), Nemaura Medical Inc. (UK), ACON Laboratories, Inc. (US), LifeScan IP Holdings, LLC (US), Ultrahuman Healthcare Pvt Ltd. (India), LifePlus (US), Prodigy Diabetes Care, LLC (US), A. Menarini Diagnostics S.r.l (Italy), Beurer GmbH (Germany), Oura Health Oy (Finland), SD Biosensor, INC (South Korea), Agatsa (India), Rossmax International Ltd (US), and Medisana Gmbh (Germany).

Research Coverage

The report provides an analysis of the blood glucose monitor market, focusing on estimating the market size and potential for future growth across various segments, including products, applications, test sites, regions, and end users. Additionally, the report features a competitive analysis of the key players in the market, detailing their company profiles, product & service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report provides valuable insights for market leaders and new entrants in the blood glucose monitor industry, offering approximate revenue figures for the overall market and its subsegments. It assists stakeholders in understanding the competitive landscape, enabling them to better position their businesses and develop effective go-to-market strategies. Additionally, the report highlights key market drivers, restraints, challenges, and opportunities, enabling stakeholders to assess the current state of the market.

This report provides insights into the following pointers:
  • Analysis of key drivers (Increasing prevalence of diabetes, Growing elderly population and increasing life expectancy, Rise in R&D investments and launch of technologically advanced products, wellness & preventive use of CGMs beyond diabetes), restraints (High cost and socioeconomic disparities in access to blood glucose sensors, Short sensor lifespan and frequent replacements), opportunities (Integration with digital health platforms and smart devices, Expansion of coverage and reimbursement policies for CGMs) and challenges (Regulatory compliance challenges for non-invasive glucose monitoring technologies, Data overload & alarm fatigue).
  • Market Penetration: It provides detailed information on the product portfolios offered by major players in the global blood glucose monitor market. The report covers various segments, including product type, application, test site, end user, and region.
  • Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global blood glucose monitor market.
  • Market Development: Thorough knowledge and analysis of the profitable rising markets by product type, application, test site, end user, and region.
  • Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global blood glucose monitor market.
  • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products and services, and capacities of the major competitors in the global blood glucose monitor market.
Tables List
Table 1 Exchange Rates Utilized For Conversion To Usd
Table 2 Risk Assessment: Blood Glucose Monitor Market
Table 3 Blood Glucose Monitor Market: Porter’s Five Forces Analysis
Table 4 Gdp Percentage Change, By Key Country, 2021–2030
Table 5 Blood Glucose Monitor Market: Role In Ecosystem
Table 6 Average Selling Price Of Blood Glucose Monitors, By Product, 2024
Table 7 Average Selling Price Trend Of Self-monitoring Blood Glucose Systems, By Region, 2022–2024
Table 8 Import Data For Hs Code 9027, By Country, 2020–2024 (Usd Thousand)
Table 9 Export Data For Hs Code 9027, By Country, 2020–2024 (Usd Thousand)
Table 10 Blood Glucose Monitor Market: List Of Key Conferences & Events, 2025–2026
Table 11 Case Study 1: Long-term Glucose Monitoring For Sensitive Skin Patients Using Senseonics’ Eversense E3 Implantable Sensor
Table 12 Case Study 2: Enhancing Patient Adherence And Glycemic Control Using Abbott’s Freestyle Libre 2 Cgm
Table 13 Case Study 3: Mproving Glycemic Control With Dexcom G6 Cgm System
Table 14 Us-adjusted Reciprocal Tariff Rates
Table 15 Key Product-related Tariffs Effective For Blood Glucose Monitor Products
Table 16 Blood Glucose Monitor Market: List Of Major Patents
Table 17 Upcoming And Pipeline Products In Global Blood Glucose Monitor Market
Table 18 Top Use Cases And Market Potential
Table 19 Blood Glucose Monitor Market: Case Studies Related To Gen Ai Implementation
Table 20 Interconnected Adjacent Ecosystems And Impact On Market Players
Table 21 North America: Regulatory Bodies, Government Agencies, And Other Organizations
Table 22 Europe: Regulatory Bodies, Government Agencies, And Other Organizations
Table 23 Asia Pacific: Regulatory Bodies, Government Agencies, And Other Organizations
Table 24 Latin America: Regulatory Bodies, Government Agencies, And Other Organizations
Table 25 Rest Of The World: Regulatory Bodies, Government Agencies, And Other Organizations
Table 26 Diabetes Prevalence, By Key Country
Table 27 Influence Of Stakeholders On Buying Process For Top Three Applications (%)
Table 28 Key Buying Criteria For Top 3 Applications
Table 29 Adoption Barriers & Internal Challenges
Table 30 Blood Glucose Monitor Market, By Product Type,
2023–2030 (Usd Million)
Table 31 Companies Offering Self-monitoring Blood Glucose (Smbg) Systems
Table 32 Self-monitoring Blood Glucose Systems Market, By Type,
2023–2030 (Usd Million)
Table 33 Self-monitoring Blood Glucose Systems Market, By Country,
2023–2030 (Usd Million)
Table 34 Self-monitoring Blood Glucose Systems Market For Glucometers,
By Region, 2023–2030 (Thousand Units)
Table 35 Self-monitoring Blood Glucose Systems Market For Glucometers,
By Country, 2023–2030 (Usd Million)
Table 36 Self-monitoring Blood Glucose Systems Market For Testing Strips,
By Country, 2023–2030 (Usd Million)
Table 37 Self-monitoring Blood Glucose Systems Market For Lancets & Lancing Devices, By Country, 2023–2030 (Usd Million)
Table 38 Companies Offering Continuous Glucose Monitoring (Cgm) Systems
Table 39 Continuous Glucose Monitoring Systems Market, By Type,
2023–2030 (Usd Million)
Table 40 Continuous Glucose Monitoring Systems Market, By Country,
2023–2030 (Usd Million)
Table 41 Continuous Glucose Monitoring Systems Market For Sensors,
By Region, 2023–2030 (Thousand Units)
Table 42 Continuous Glucose Monitoring Systems Market For Sensors,
By Country, 2023–2030 (Usd Million)
Table 43 Continuous Glucose Monitoring Systems Market For Implants,
By Country, 2023–2030 (Usd Million)
Table 44 Continuous Glucose Monitoring Systems Market For Transmitters & Receivers, By Country, 2023–2030 (Usd Million)
Table 45 Companies Offering Professional Point-of-care Devices
Table 46 Professional Point-of-care Devices Market, By Country,
2023–2030 (Usd Million)
Table 47 Companies Offering Non-invasive Products
Table 48 Non-invasive Products Market, By Country, 2023–2030 (Usd Million)
Table 49 Blood Glucose Monitor Market, By Test Site, 2023–2030 (Usd Million)
Table 50 Blood Glucose Monitor Market For Fingertip Testing, By Country, 2023–2030 (Usd Million)
Table 51 Blood Glucose Monitor Market For Upper Arm Testing, By Country, 2023–2030 (Usd Million)
Table 52 Blood Glucose Monitor Market For Other Test Sites, By Country, 2023–2030 (Usd Million)
Table 53 Blood Glucose Monitor Market, By Application, 2023–2030 (Usd Million)
Table 54 Blood Glucose Monitor Market For Diabetes Management, By Type, 2023–2030 (Usd Million)
Table 55 Blood Glucose Monitor Market For Diabetes Management, By Country, 2023–2030 (Usd Million)
Table 56 Blood Glucose Monitor Market For Type 1 Diabetes, By Country,
2023–2030 (Usd Million)
Table 57 Blood Glucose Monitor Market For Type 2 Diabetes, By Country,
2023–2030 (Usd Million)
Table 58 Blood Glucose Monitor Market For Health & Wellness Monitoring,
By Country, 2023–2030 (Usd Million)
Table 59 Blood Glucose Monitor Market For Other Applications, By Country, 2023–2030 (Usd Million)
Table 60 Blood Glucose Monitor Market, By End User, 2023–2030 (Usd Million)
Table 61 Blood Glucose Monitor Market For Self/Home Care, By Country, 2023–2030 (Usd Million)
Table 62 Blood Glucose Monitor Market For Hospitals & Clinics, By Country, 2023–2030 (Usd Million)
Table 63 Blood Glucose Monitor Market For Other End User, By Country,
2023–2030 (Usd Million)
Table 64 Blood Glucose Monitor Market, By Region, 2023–2030 (Usd Million)
Table 65 North America: Blood Glucose Monitor Market, By Country,
2023–2030 (Usd Million)
Table 66 North America: Blood Glucose Monitor Market, By Product Type, 2023–2030 (Usd Million)
Table 67 North America: Self-monitoring Blood Glucose Systems Market,
By Type, 2023–2030 (Usd Million)
Table 68 North America: Continuous Glucose Monitoring Systems Market,
By Type, 2023–2030 (Usd Million)
Table 69 North America: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 70 North America: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 71 North America: Blood Glucose Monitor Market For Diabetes Management, By Type, 2023–2030 (Usd Million)
Table 72 North America: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 73 Us: Blood Glucose Monitor Market, By Product Type,
2023–2030 (Usd Million)
Table 74 Us: Self-monitoring Blood Glucose Systems Market, By Type,
2023–2030 (Usd Million)
Table 75 Us: Continuous Glucose Monitoring Systems Market, By Type,
2023–2030 (Usd Million)
Table 76 Us: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 77 Us: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 78 Us: Blood Glucose Monitor Market For Diabetes Management, By Type, 2023–2030 (Usd Million)
Table 79 Us: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 80 Canada: Blood Glucose Monitor Market, By Product Type,
2023–2030 (Usd Million)
Table 81 Canada: Self-monitoring Blood Glucose Systems Market, By Type, 2023–2030 (Usd Million)
Table 82 Canada: Continuous Glucose Monitoring Systems Market, By Type, 2023–2030 (Usd Million)
Table 83 Canada: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 84 Canada: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 85 Canada: Blood Glucose Monitor Market For Diabetes Management,
By Type, 2023–2030 (Usd Million)
Table 86 Canada: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 87 Europe: Blood Glucose Monitor Market, By Country,
2023–2030 (Usd Million)
Table 88 Europe: Blood Glucose Monitor Market, By Product Type,
2023–2030 (Usd Million)
Table 89 Europe: Self-monitoring Blood Glucose Systems Market, By Type, 2023–2030 (Usd Million)
Table 90 Europe: Continuous Glucose Monitoring Systems Market, By Type, 2023–2030 (Usd Million)
Table 91 Europe: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 92 Europe: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 93 Europe: Blood Glucose Monitor Market For Diabetes Management,
By Type, 2023–2030 (Usd Million)
Table 94 Europe: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 95 Germany: Blood Glucose Monitor Market, By Product Type,
2023–2030 (Usd Million)
Table 96 Germany: Self-monitoring Blood Glucose Systems Market, By Type, 2023–2030 (Usd Million)
Table 97 Germany: Continuous Glucose Monitoring Systems Market, By Type, 2023–2030 (Usd Million)
Table 98 Germany: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 99 Germany: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 100 Germany: Blood Glucose Monitor Market For Diabetes Management,
By Type, 2023–2030 (Usd Million)
Table 101 Germany: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 102 Uk: Blood Glucose Monitor Market, By Product Type,
2023–2030 (Usd Million)
Table 103 Uk: Self-monitoring Blood Glucose Systems Market, By Type,
2023–2030 (Usd Million)
Table 104 Uk: Continuous Glucose Monitoring Systems Market, By Type,
2023–2030 (Usd Million)
Table 105 Uk: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 106 Uk: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 107 Uk: Blood Glucose Monitor Market For Diabetes Management, By Type, 2023–2030 (Usd Million)
Table 108 Uk: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 109 France: Blood Glucose Monitor Market, By Product Type,
2023–2030 (Usd Million)
Table 110 France: Self-monitoring Blood Glucose Systems Market, By Type, 2023–2030 (Usd Million)
Table 111 France: Continuous Glucose Monitoring Systems Market, By Type, 2023–2030 (Usd Million)
Table 112 France: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 113 France: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 114 France: Blood Glucose Monitor Market For Diabetes Management,
By Type, 2023–2030 (Usd Million)
Table 115 France: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 116 Italy: Blood Glucose Monitor Market, By Product Type,
2023–2030 (Usd Million)
Table 117 Italy: Self-monitoring Blood Glucose Systems Market, By Type,
2023–2030 (Usd Million)
Table 118 Italy: Continuous Glucose Monitoring Systems Market, By Type,
2023–2030 (Usd Million)
Table 119 Italy: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 120 Italy: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 121 Italy: Blood Glucose Monitor Market For Diabetes Management,
By Type, 2023–2030 (Usd Million)
Table 122 Italy: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 123 Spain: Blood Glucose Monitor Market, By Product Type,
2023–2030 (Usd Million)
Table 124 Spain: Self-monitoring Blood Glucose Systems Market, By Type,
2023–2030 (Usd Million)
Table 125 Spain: Continuous Glucose Monitoring Systems Market, By Type,
2023–2030 (Usd Million)
Table 126 Spain: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 127 Spain: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 128 Spain: Blood Glucose Monitor Market For Diabetes Management,
By Type, 2023–2030 (Usd Million)
Table 129 Spain: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 130 Rest Of Europe: Blood Glucose Monitor Market, By Product Type, 2023–2030 (Usd Million)
Table 131 Rest Of Europe: Self-monitoring Blood Glucose Systems Market,
By Type, 2023–2030 (Usd Million)
Table 132 Rest Of Europe: Continuous Glucose Monitoring Systems Market,
By Type, 2023–2030 (Usd Million)
Table 133 Rest Of Europe: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 134 Rest Of Europe: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 135 Rest Of Europe: Blood Glucose Monitor Market For Diabetes Management, By Type, 2023–2030 (Usd Million)
Table 136 Rest Of Europe: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 137 Asia Pacific: Blood Glucose Monitor Market, By Country,
2023–2030 (Usd Million)
Table 138 Asia Pacific: Blood Glucose Monitor Market, By Product Type,
2023–2030 (Usd Million)
Table 139 Asia Pacific: Self-monitoring Blood Glucose Systems Market, By Type, 2023–2030 (Usd Million)
Table 140 Asia Pacific: Continuous Glucose Monitoring Systems Market, By Type, 2023–2030 (Usd Million)
Table 141 Asia Pacific: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 142 Asia Pacific: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 143 Asia Pacific: Blood Glucose Monitor Market For Diabetes Management, By Type, 2023–2030 (Usd Million)
Table 144 Asia Pacific: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 145 China: Blood Glucose Monitor Market, By Product Type,
2023–2030 (Usd Million)
Table 146 China: Self-monitoring Blood Glucose Systems Market, By Type,
2023–2030 (Usd Million)
Table 147 China: Continuous Glucose Monitoring Systems Market, By Type,
2023–2030 (Usd Million)
Table 148 China: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 149 China: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 150 China: Blood Glucose Monitor Market For Diabetes Management,
By Type, 2023–2030 (Usd Million)
Table 151 China: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 152 Japan: Blood Glucose Monitor Market, By Product Type,
2023–2030 (Usd Million)
Table 153 Japan: Self-monitoring Blood Glucose Systems Market, By Type,
2023–2030 (Usd Million)
Table 154 Japan: Continuous Glucose Monitoring Systems Market, By Type,
2023–2030 (Usd Million)
Table 155 Japan: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 156 Japan: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 157 Japan: Blood Glucose Monitor Market For Diabetes Management,
By Type, 2023–2030 (Usd Million)
Table 158 Japan: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 159 India: Blood Glucose Monitor Market, By Product Type,
2023–2030 (Usd Million)
Table 160 India: Self-monitoring Blood Glucose Systems Market, By Type,
2023–2030 (Usd Million)
Table 161 India: Continuous Glucose Monitoring Systems Market, By Type,
2023–2030 (Usd Million)
Table 162 India: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 163 India: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 164 India: Blood Glucose Monitor Market For Diabetes Management,
By Type, 2023–2030 (Usd Million)
Table 165 India: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 166 Australia: Blood Glucose Monitor Market, By Product Type,
2023–2030 (Usd Million)
Table 167 Australia: Self-monitoring Blood Glucose Systems Market, By Type, 2023–2030 (Usd Million)
Table 168 Australia: Continuous Glucose Monitoring Systems Market, By Type, 2023–2030 (Usd Million)
Table 169 Australia: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 170 Australia: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 171 Australia: Blood Glucose Monitor Market For Diabetes Management, By Type, 2023–2030 (Usd Million)
Table 172 Australia: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 173 South Korea: Blood Glucose Monitor Market, By Product Type,
2023–2030 (Usd Million)
Table 174 South Korea: Self-monitoring Blood Glucose Systems Market, By Type, 2023–2030 (Usd Million)
Table 175 South Korea: Continuous Glucose Monitoring Systems Market, By Type, 2023–2030 (Usd Million)
Table 176 South Korea: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 177 South Korea: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 178 South Korea: Blood Glucose Monitor Market For Diabetes Management, By Type, 2023–2030 (Usd Million)
Table 179 South Korea: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 180 Rest Of Asia Pacific: Blood Glucose Monitor Market, By Product Type, 2023–2030 (Usd Million)
Table 181 Rest Of Asia Pacific: Self-monitoring Blood Glucose Systems Market, By Type, 2023–2030 (Usd Million)
Table 182 Rest Of Asia Pacific: Continuous Glucose Monitoring Systems Market, By Type, 2023–2030 (Usd Million)
Table 183 Rest Of Asia Pacific: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 184 Rest Of Asia Pacific: Blood Glucose Monitor Market, By Application, 2023–2030 (Usd Million)
Table 185 Rest Of Asia Pacific: Blood Glucose Monitor Market For Diabetes Management, By Type, 2023–2030 (Usd Million)
Table 186 Rest Of Asia Pacific: Blood Glucose Monitor Market, By End User, 2023–2030 (Usd Million)
Table 187 Latin America: Blood Glucose Monitor Market, By Country,
2023–2030 (Usd Million)
Table 188 Latin America: Blood Glucose Monitor Market, By Product Type,
2023–2030 (Usd Million)
Table 189 Latin America: Self-monitoring Blood Glucose Systems Market, By Type, 2023–2030 (Usd Million)
Table 190 Latin America: Continuous Glucose Monitoring Systems Market,
By Type, 2023–2030 (Usd Million)
Table 191 Latin America: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 192 Latin America: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 193 Latin America: Blood Glucose Monitor Market For Diabetes Management, By Type, 2023–2030 (Usd Million)
Table 194 Latin America: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 195 Brazil: Blood Glucose Monitor Market, By Product Type,
2023–2030 (Usd Million)
Table 196 Brazil: Self-monitoring Blood Glucose Systems Market, By Type,
2023–2030 (Usd Million)
Table 197 Brazil: Continuous Glucose Monitoring Systems Market, By Type, 2023–2030 (Usd Million)
Table 198 Brazil: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 199 Brazil: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 200 Brazil: Blood Glucose Monitor Market For Diabetes Management,
By Type, 2023–2030 (Usd Million)
Table 201 Brazil: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 202 Mexico: Blood Glucose Monitor Market, By Product Type,
2023–2030 (Usd Million)
Table 203 Mexico: Self-monitoring Blood Glucose Systems Market, By Type, 2023–2030 (Usd Million)
Table 204 Mexico: Continuous Glucose Monitoring Systems Market, By Type, 2023–2030 (Usd Million)
Table 205 Mexico: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 206 Mexico: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 207 Mexico: Blood Glucose Monitor Market For Diabetes Management,
By Type, 2023–2030 (Usd Million)
Table 208 Mexico: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 209 Rest Of Latin America: Blood Glucose Monitor Market, By Product Type, 2023–2030 (Usd Million)
Table 210 Rest Of Latin America: Self-monitoring Blood Glucose Systems Market, By Type, 2023–2030 (Usd Million)
Table 211 Rest Of Latin America: Continuous Glucose Monitoring Systems Market, By Type, 2023–2030 (Usd Million)
Table 212 Rest Of Latin America: Blood Glucose Monitor Market, By Test Site, 2023–2030 (Usd Million)
Table 213 Rest Of Latin America: Blood Glucose Monitor Market, By Application, 2023–2030 (Usd Million)
Table 214 Rest Of Latin America: Blood Glucose Monitor Market For Diabetes Management, By Type, 2023–2030 (Usd Million)
Table 215 Rest Of Latin America: Blood Glucose Monitor Market, By End User, 2023–2030 (Usd Million)
Table 216 Middle East & Africa: Blood Glucose Monitor Market, By Product Type, 2023–2030 (Usd Million)
Table 217 Middle East & Africa: Self-monitoring Blood Glucose Systems Market, By Type, 2023–2030 (Usd Million)
Table 218 Middle East & Africa: Continuous Glucose Monitoring Systems Market, By Type, 2023–2030 (Usd Million)
Table 219 Middle East & Africa: Blood Glucose Monitor Market, By Test Site, 2023–2030 (Usd Million)
Table 220 Middle East & Africa: Blood Glucose Monitor Market, By Application, 2023–2030 (Usd Million)
Table 221 Middle East & Africa: Blood Glucose Monitor Market For Diabetes Management, By Type, 2023–2030 (Usd Million)
Table 222 Middle East & Africa: Blood Glucose Monitor Market, By End User, 2023–2030 (Usd Million)
Table 223 Gcc Countries: Blood Glucose Monitor Market, By Product Type,
2023–2030 (Usd Million)
Table 224 Gcc Countries: Self-monitoring Blood Glucose Systems Market,
By Type, 2023–2030 (Usd Million)
Table 225 Gcc Countries: Continuous Glucose Monitoring Systems Market,
By Type, 2023–2030 (Usd Million)
Table 226 Gcc Countries: Blood Glucose Monitor Market, By Test Site,
2023–2030 (Usd Million)
Table 227 Gcc Countries: Blood Glucose Monitor Market, By Application,
2023–2030 (Usd Million)
Table 228 Gcc Countries: Blood Glucose Monitor Market For Diabetes Management, By Type, 2023–2030 (Usd Million)
Table 229 Gcc Countries: Blood Glucose Monitor Market, By End User,
2023–2030 (Usd Million)
Table 230 Strategies Adopted By Key Players In Blood Glucose Monitor Market, January 2022–september 2025
Table 231 Blood Glucose Monitor Market: Degree Of Competition
Table 232 Blood Glucose Monitor Market: Region Footprint
Table 233 Blood Glucose Monitor Market: Product Type Footprint
Table 234 Blood Glucose Monitor Market: Test Site Footprint
Table 235 Blood Glucose Monitor Market: Application Footprint
Table 236 Blood Glucose Monitor Market: Detailed List Of Key Startups/Smes
Table 237 Blood Glucose Monitor Market: Competitive Benchmarking Of Key Startups/Smes (1/2)
Table 238 Blood Glucose Monitor Market: Competitive Benchmarking Of Key Startups/Smes (2/2)
Table 239 Blood Glucose Monitor Market: Product Launches & Approvals, January 2022–september 2025
Table 240 Blood Glucose Monitor Market: Deals, January 2022–september 2025
Table 241 Blood Glucose Monitor Market: Expansions,
January 2022–september 2025
Table 242 Blood Glucose Monitor Market: Other Developments,
January 2022–september 2025
Table 243 Abbott Laboratories: Company Overview
Table 244 Abbott Laboratories: Products Offered
Table 245 Abbott Laboratories: Product Launches & Approvals,
January 2022–september 2025
Table 246 Abbott Laboratories: Deals, January 2022–september 2025
Table 247 Abbott Laboratories: Expansions, January 2022–september 2025
Table 248 Abbott Laboratories: Other Developments,
January 2022–september 2025
Table 249 Dexcom, Inc.: Company Overview
Table 250 Dexcom, Inc.: Products Offered
Table 251 Dexcom, Inc.: Product Launches & Approvals,
January 2022–september 2025
Table 252 Dexcom, Inc.: Deals, January 2022–september 2025
Table 253 Medtronic: Company Overview
Table 254 Medtronic: Products Offered
Table 255 Medtronic: Product Approvals, January 2022–september 2025
Table 256 Medtronic: Deals, January 2022–september 2025
Table 257 Medtronic: Expansions, January 2022–september 2025
Table 258 Medtronic: Other Developments, January 2022–september 2025
Table 259 Sinocare: Company Overview
Table 260 Sinocare: Products Offered
Table 261 Sinocare: Product Approvals, January 2022–september 2025
Table 262 Sinocare: Deals, January 2022–september 2025
Table 263 Sinocare: Other Developments, January 2022–september 2025
Table 264 F. Hoffmann-la Roche Ltd.: Company Overview
Table 265 F. Hoffmann-la Roche Ltd.: Products Offered
Table 266 F. Hoffmann-la Roche Ltd.: Products Launches & Approvals,
January 2022–september 2025
Table 267 F. Hoffmann-la Roche Ltd.: Expansions, January 2022–september 2025
Table 268 B. Braun Se: Company Overview
Table 269 B. Braun Se: Products Offered
Table 270 I-sens, Inc.: Company Overview
Table 271 I-sens, Inc.: Products Offered
Table 272 I-sens, Inc.: Product Approvals, January 2022–september 2025
Table 273 I-sens, Inc.: Deals, January 2022–september 2025
Table 274 Senseonics: Company Overview
Table 275 Senseonics: Products Offered
Table 276 Senseonics: Product Launches & Approvals,
January 2022–september 2025
Table 277 Senseonics: Deals, January 2022–september 2025
Table 278 Senseonics: Other Developments, January 2022–september 2025
Table 279 Ascensia Diabetes Care Holdings Ag: Company Overview
Table 280 Ascensia Diabetes Care Holdings Ag: Products Offered
Table 281 Ascensia Diabetes Care Holdings Ag: Product Launches,
January 2022–september 2025
Table 282 Ascensia Diabetes Care Holdings Ag: Deals,
January 2022–september 2025
Table 283 Nipro: Company Overview
Table 284 Nipro: Products Offered
Table 285 Nipro: Expansions, January 2022–september 2025
Table 286 Nemaura Medical Inc.: Company Overview
Table 287 Nemaura Medical Inc.: Products Offered
Table 288 Nemaura Medical Inc.: Other Developments,
January 2022–september 2025
Table 289 Medical Technology And Devices S.P.A.: Company Overview
Table 290 Medical Technology And Devices S.P.A.: Products Offered
Table 291 Medical Technology And Devices S.P.A.: Deals,
January 2022–september 2025
Table 292 Terumo Corporation: Company Overview
Table 293 Terumo Corporation: Products Offered
Table 294 Terumo Corporation: Deals, January 2022–september 2025
Table 295 Terumo Corporation: Expansions, January 2022–september 2025
Table 296 Terumo Corporation: Other Developments,
January 2022–september 2025
Table 297 Lifescan Ip Holdings, Llc: Company Overview
Table 298 Lifescan Ip Holdings, Llc: Products Offered
Table 299 Lifescan Ip Holdings, Llc: Deals, January 2022–september 2025
ket, By Application, 2023–2030 (Usd Million)
Table 284 China: Patient-derived Xenograft (Pdx) Models Market, By End User, 2023–2030 (Usd Million)
Table 285 Japan: Patient-derived Xenograft (Pdx) Models Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 286 Japan: Pdx Models Market, By Type, 2023–2030 (Usd Million)
Table 287 Japan: Pdx Services Market, By Type, 2023–2030 (Usd Million)
Table 288 Japan: Patient-derived Xenograft (Pdx) Models Market, By Implantation Method, 2023–2030 (Usd Million)
Table 289 Japan: Patient-derived Xenograft (Pdx) Models Market, By Tumor Type, 2023–2030 (Usd Million)
Table 290 Japan: Patient-derived Xenograft (Pdx) Models Market, By Application, 2023–2030 (Usd Million)
Table 291 Japan: Patient-derived Xenograft (Pdx) Models Market, By End User, 2023–2030 (Usd Million)
Table 292 India: Patient-derived Xenograft (Pdx) Models Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 293 India: Pdx Models Market, By Type, 2023–2030 (Usd Million)
Table 294 India: Pdx Services Market, By Type, 2023–2030 (Usd Million)
Table 295 India: Patient-derived Xenograft (Pdx) Models Market, By Implantation Method, 2023–2030 (Usd Million)
Table 296 India: Patient-derived Xenograft (Pdx) Models Market, By Tumor Type, 2023–2030 (Usd Million)
Table 297 India: Patient-derived Xenograft (Pdx) Models Market, By Application, 2023–2030 (Usd Million)
Table 298 India: Patient-derived Xenograft (Pdx) Models Market, By End User, 2023–2030 (Usd Million)
Table 299 Australia: Patient-derived Xenograft (Pdx) Models Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 300 Australia: Pdx Models Market, By Type, 2023–2030 (Usd Million)
Table 301 Australia: Pdx Services Market, By Type, 2023–2030 (Usd Million)
Table 302 Australia: Patient-derived Xenograft (Pdx) Models Market, By Implantation Method, 2023–2030 (Usd Million)
Table 303 Australia: Patient-derived Xenograft (Pdx) Models Market, By Tumor Type, 2023–2030 (Usd Million)
Table 304 Australia: Patient-derived Xenograft (Pdx) Models Market, By Application, 2023–2030 (Usd Million)
Table 305 Australia: Patient-derived Xenograft (Pdx) Models Market, By End User, 2023–2030 (Usd Million)
Table 306 South Korea: Patient-derived Xenograft (Pdx) Models Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 307 South Korea: Pdx Models Market, By Type, 2023–2030 (Usd Million)
Table 308 South Korea: Pdx Services Market, By Type, 2023–2030 (Usd Million)
Table 309 South Korea: Patient-derived Xenograft (Pdx) Models Market, By Implantation Method, 2023–2030 (Usd Million)
Table 310 South Korea: Patient-derived Xenograft (Pdx) Models Market, By Tumor Type, 2023–2030 (Usd Million)
Table 311 South Korea: Patient-derived Xenograft (Pdx) Models Market, By Application, 2023–2030 (Usd Million)
Table 312 South Korea: Patient-derived Xenograft (Pdx) Models Market, By End User, 2023–2030 (Usd Million)
Table 313 Rest Of Asia Pacific: Patient-derived Xenograft (Pdx) Models Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 314 Rest Of Asia Pacific: Pdx Models Market, By Type, 2023–2030 (Usd Million)
Table 315 Rest Of Asia Pacific: Pdx Services Market, By Type, 2023–2030 (Usd Million)
Table 316 Rest Of Asia Pacific: Patient-derived Xenograft (Pdx) Models Market, By Implantation Method, 2023–2030 (Usd Million)
Table 317 Rest Of Asia Pacific: Patient-derived Xenograft (Pdx) Models Market, By Tumor Type, 2023–2030 (Usd Million)
Table 318 Rest Of Asia Pacific: Patient-derived Xenograft (Pdx) Models Market, By Application, 2023–2030 (Usd Million)
Table 319 Rest Of Asia Pacific: Patient-derived Xenograft (Pdx) Models Market, By End User, 2023–2030 (Usd Million)
Table 320 Latin America: Patient-derived Xenograft (Pdx) Models Market, By Country, 2023–2030 (Usd Million)
Table 321 Latin America: Patient-derived Xenograft (Pdx) Models Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 322 Latin America: Pdx Models Market, By Type, 2023–2030 (Usd Million)
Table 323 Latin America: Pdx Services Market, By Type, 2023–2030 (Usd Million)
Table 324 Latin America: Patient-derived Xenograft (Pdx) Models Market, By Implantation Method, 2023–2030 (Usd Million)
Table 325 Latin America: Patient-derived Xenograft (Pdx) Models Market, By Tumor Type, 2023–2030 (Usd Million)
Table 326 Latin America: Patient-derived Xenograft (Pdx) Models Market, By Application, 2023–2030 (Usd Million)
Table 327 Latin America: Patient-derived Xenograft (Pdx) Models Market, By End User, 2023–2030 (Usd Million)
Table 328 Brazil: Patient-derived Xenograft (Pdx) Models Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 329 Brazil: Pdx Models Market, By Type, 2023–2030 (Usd Million)
Table 330 Brazil: Pdx Services Market, By Type, 2023–2030 (Usd Million)
Table 331 Brazil: Patient-derived Xenograft (Pdx) Models Market, By Implantation Method, 2023–2030 (Usd Million)
Table 332 Brazil: Patient-derived Xenograft (Pdx) Models Market, By Tumor Type, 2023–2030 (Usd Million)
Table 333 Brazil: Patient-derived Xenograft (Pdx) Models Market, By Application, 2023–2030 (Usd Million)
Table 334 Brazil: Patient-derived Xenograft (Pdx) Models Market, By End User, 2023–2030 (Usd Million)
Table 335 Mexico: Patient-derived Xenograft (Pdx) Models Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 336 Mexico: Pdx Models Market, By Type, 2023–2030 (Usd Million)
Table 337 Mexico: Pdx Services Market, By Type, 2023–2030 (Usd Million)
Table 338 Mexico: Patient-derived Xenograft (Pdx) Models Market, By Implantation Method, 2023–2030 (Usd Million)
Table 339 Mexico: Patient-derived Xenograft (Pdx) Models Market, By Tumor Type, 2023–2030 (Usd Million)
Table 340 Mexico: Patient-derived Xenograft (Pdx) Models Market, By Application, 2023–2030 (Usd Million)
Table 341 Mexico: Patient-derived Xenograft (Pdx) Models Market, By End User, 2023–2030 (Usd Million)
Table 342 Rest Of Latin America: Patient-derived Xenograft (Pdx) Models Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 343 Rest Of Latin America: Pdx Models Market, By Type, 2023–2030 (Usd Million)
Table 344 Rest Of Latin America: Pdx Services Market, By Type, 2023–2030 (Usd Million)
Table 345 Rest Of Latin America: Patient-derived Xenograft (Pdx) Models Market, By Implantation Method, 2023–2030 (Usd Million)
Table 346 Rest Of Latin America: Patient-derived Xenograft (Pdx) Models Market, By Tumor Type, 2023–2030 (Usd Million)
Table 347 Rest Of Latin America: Patient-derived Xenograft (Pdx) Models Market, By Application, 2023–2030 (Usd Million)
Table 348 Rest Of Latin America: Patient-derived Xenograft (Pdx) Models Market, By End User, 2023–2030 (Usd Million)
Table 349 Middle East: Patient-derived Xenograft (Pdx) Models Market, By Region, 2023–2030 (Usd Million)
Table 350 Middle East: Patient-derived Xenograft (Pdx) Models Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 351 Middle East: Pdx Models Market, By Type, 2023–2030 (Usd Million)
Table 352 Middle East: Pdx Services Market, By Type, 2023–2030 (Usd Million)
Table 353 Middle East: Patient-derived Xenograft (Pdx) Models Market, By Implantation Method, 2023–2030 (Usd Million)
Table 354 Middle East: Patient-derived Xenograft (Pdx) Models Market, By Tumor Type, 2023–2030 (Usd Million)
Table 355 Middle East: Patient-derived Xenograft (Pdx) Models Market, By Application, 2023–2030 (Usd Million)
Table 356 Middle East: Patient-derived Xenograft (Pdx) Models Market, By End User, 2023–2030 (Usd Million)
Table 357 Gcc Countries: Patient-derived Xenograft (Pdx) Models Market, By Country, 2023–2030 (Usd Million)
Table 358 Gcc Countries: Patient-derived Xenograft (Pdx) Models Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 359 Gcc Countries: Pdx Models Market, By Type, 2023–2030 (Usd Million)
Table 360 Gcc Countries: Pdx Services Market, By Type, 2023–2030 (Usd Million)
Table 361 Gcc Countries: Patient-derived Xenograft (Pdx) Models Market, By Implantation Method, 2023–2030 (Usd Million)
Table 362 Gcc Countries: Patient-derived Xenograft (Pdx) Models Market, By Tumor Type, 2023–2030 (Usd Million)
Table 363 Gcc Countries: Patient-derived Xenograft (Pdx) Models Market, By Application, 2023–2030 (Usd Million)
Table 364 Gcc Countries: Patient-derived Xenograft (Pdx) Models Market, By End User, 2023–2030 (Usd Million)
Table 365 Kingdom Of Saudi Arabia: Patient-derived Xenograft (Pdx) Models Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 366 Kingdom Of Saudi Arabia: Pdx Models Market, By Type, 2023–2030 (Usd Million)
Table 367 Kingdom Of Saudi Arabia: Pdx Services Market, By Type, 2023–2030 (Usd Million)
Table 368 Kingdom Of Saudi Arabia: Patient-derived Xenograft (Pdx) Models Market, By Implantation Method, 2023–2030 (Usd Million)
Table 369 Kingdom Of Saudi Arabia: Patient-derived Xenograft (Pdx) Models Market, By Tumor Type, 2023–2030 (Usd Million)
Table 370 Kingdom Of Saudi Arabia: Patient-derived Xenograft (Pdx) Models Market, By Application, 2023–2030 (Usd Million)
Table 371 Kingdom Of Saudi Arabia: Patient-derived Xenograft (Pdx) Models Market, By End User, 2023–2030 (Usd Million)
Table 372 Uae: Patient-derived Xenograft (Pdx) Models Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 373 Uae: Pdx Models Market, By Type, 2023–2030 (Usd Million)
Table 374 Uae: Pdx Services Market, By Type, 2023–2030 (Usd Million)
Table 375 Uae: Patient-derived Xenograft (Pdx) Models Market, By Implantation Method, 2023–2030 (Usd Million)
Table 376 Uae: Patient-derived Xenograft (Pdx) Models Market, By Tumor Type, 2023–2030 (Usd Million)
Table 377 Uae: Patient-derived Xenograft (Pdx) Models Market, By Application, 2023–2030 (Usd Million)
Table 378 Uae: Patient-derived Xenograft (Pdx) Models Market, By End User, 2023–2030 (Usd Million)
Table 379 Rest Of Gcc Countries: Patient-derived Xenograft (Pdx) Models Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 380 Rest Of Gcc Countries: Pdx Models Market, By Type, 2023–2030 (Usd Million)
Table 381 Rest Of Gcc Countries: Pdx Services Market, By Type, 2023–2030 (Usd Million)
Table 382 Rest Of Gcc Countries: Patient-derived Xenograft (Pdx) Models Market, By Implantation Method, 2023–2030 (Usd Million)
Table 383 Rest Of Gcc Countries: Patient-derived Xenograft (Pdx) Models Market, By Tumor Type, 2023–2030 (Usd Million)
Table 384 Rest Of Gcc Countries: Patient-derived Xenograft (Pdx) Models Market, By Application, 2023–2030 (Usd Million)
Table 385 Rest Of Gcc Countries: Patient-derived Xenograft (Pdx) Models Market, By End User, 2023–2030 (Usd Million)
Table 386 Rest Of Middle East: Patient-derived Xenograft (Pdx) Models Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 387 Rest Of Middle East: Pdx Models Market, By Type, 2023–2030 (Usd Million)
Table 388 Rest Of Middle East: Pdx Services Market, By Type, 2023–2030 (Usd Million)
Table 389 Rest Of Middle East: Patient-derived Xenograft (Pdx) Models Market, By Implantation Method, 2023–2030 (Usd Million)
Table 390 Rest Of Middle East: Patient-derived Xenograft (Pdx) Models Market, By Tumor Type, 2023–2030 (Usd Million)
Table 391 Rest Of Middle East: Patient-derived Xenograft (Pdx) Models Market, By Application, 2023–2030 (Usd Million)
Table 392 Rest Of Middle East: Patient-derived Xenograft (Pdx) Models Market, By End User, 2023–2030 (Usd Million)
Table 393 Africa: Patient-derived Xenograft (Pdx) Models Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 394 Africa: Pdx Models Market, By Type, 2023–2030 (Usd Million)
Table 395 Africa: Pdx Services Market, By Type, 2023–2030 (Usd Million)
Table 396 Africa: Patient-derived Xenograft (Pdx) Models Market, By Implantation Method, 2023–2030 (Usd Million)
Table 397 Africa: Patient-derived Xenograft (Pdx) Models Market, By Tumor Type, 2023–2030 (Usd Million)
Table 398 Africa: Patient-derived Xenograft (Pdx) Models Market, By Application, 2023–2030 (Usd Million)
Table 399 Africa: Patient-derived Xenograft (Pdx) Models Market, By End User, 2023–2030 (Usd Million)
Table 400 Strategies Adopted By Key Players In Patient-derived Xenograft (Pdx) Models Market, 2022−2025
Table 401 Patient-derived Xenograft (Pdx) Models Market: Degree Of Competition
Table 402 Patient-derived Xenograft (Pdx) Models Market: Region Footprint
Table 403 Patient-derived Xenograft (Pdx) Models Market: Model Type & Service Footprint
Table 404 Patient-derived Xenograft (Pdx) Models Market: Tumor Type Footprint
Table 405 Patient-derived Xenograft (Pdx) Models Market: Implantation Method Footprint
Table 406 Patient-derived Xenograft (Pdx) Models Market: Detailed List Of Key Startups/Sme Players
Table 407 Patient-derived Xenograft (Pdx) Models Market: Competitive Benchmarking Of Key Startups/Sme Players, By Model Type & Service And Region
Table 408 Patient-derived Xenograft (Pdx) Models Market: Deals, January 2022− October 2025
Table 409 Patient-derived Xenograft (Pdx) Models Market: Expansions, January 2022− October 2025
Table 410 Charles River Laboratories: Company Overview
Table 411 Charles River Laboratories: Products/Services Offered
Table 412 Charles River Laboratories: Deals, January 2022–october 2025
Table 413 Charles River Laboratories: Expansions, January 2022–october 2025
Table 414 The Jackson Laboratory: Company Overview
Table 415 The Jackson Laboratory: Products/Services Offered
Table 416 The Jackson Laboratory: Deals, January 2022–october 2025
Table 417 The Jackson Laboratory: Expansions, January 2022–october 2025
Table 418 Inotiv: Company Overview
Table 419 Inotiv: Products/Services Offered
Table 420 Inotiv: Expansions, January 2022–october 2025
Table 421 Jsr Corporation: Company Overview
Table 422 Jsr Corporation: Products/Services Offered
Table 423 Jsr Corporation: Deals, January 2022–october 2025
Table 424 Jsr Corporation: Expansions, January 2022–october 2025
Table 425 Genoway: Company Overview
Table 426 Genoway: Products/Services Offered
Table 427 Wuxi Apptec + Wuxi Biologics: Company Overview
Table 428 Wuxi Apptec + Wuxi Biologics: Products/Services Offered
Table 429 Wuxi Apptec + Wuxi Biologics: Deals, January 2022–october 2025
Table 430 Wuxi Apptec + Wuxi Biologics: Expansions, January 2022–october 2025
Table 431 Biocytogen Pharmaceuticals Co., Ltd.: Company Overview
Table 432 Biocytogen Pharmaceuticals Co., Ltd.: Products/Services Offered
Table 433 Biocytogen Pharmaceuticals Co., Ltd.: Product/Service Upgrades, January 2022–october 2025
Table 434 Biocytogen Pharmaceuticals Co., Ltd.: Expansions, January 2022–october 2025
Table 435 Taconic Biosciences, Inc.: Company Overview
Table 436 Taconic Biosciences, Inc.: Products/Services Offered
Table 437 Taconic Biosciences, Inc.: Product/Service Launches, January 2022–october 2025
Table 438 Taconic Biosciences, Inc.: Deals, January 2022–october 2025
Table 439 Taconic Biosciences, Inc.: Expansions, January 2022–october 2025
Table 440 Oncodesign Services (Oncodesign Precision Medicine): Company Overview
Table 441 Oncodesign Services (Oncodesign Precision Medicine): Products/Services Offered
Table 442 Champions Oncology, Inc.: Company Overview
Table 443 Champions Oncology, Inc.: Products/Services Offered
Table 444 Champions Oncology, Inc.: Deals, January 2022–october 2025
Table 445 Pharmaron: Company Overview
Table 446 Pharmaron: Products/Services Offered
Table 447 Syngene International Limited: Company Overview
Table 448 Syngene International Limited: Products/Services Offered
Table 449 Labcorp: Company Overview
Table 450 Labcorp: Products/Services Offered
Table 451 Eurofins Scientific: Company Overview
Table 452 Eurofins Scientific: Products/Services Offered
Table 453 Vitalstar Biotechnology Co., Ltd.: Company Overview
Table 454 Vitalstar Biotechnology Co., Ltd.: Products/Services Offered
Table 455 Creative Animodel: Company Overview
Table 456 Joinn Laboratories (China) Co., Ltd.: Company Overview
Table 457 Creative Biolabs: Company Overview
Table 458 Aragen Life Sciences Ltd.: Business Overview
Table 459 Pharmatest: Business Overview
Table 460 Lide Shanghai Biotech Co., Ltd.: Company Overview
Table 461 Certis Oncology Solutions: Company Overview
Table 462 Innoser: Company Overview
Table 463 Shanghai Chempartner: Company Overview
Table 464 Ivrs Ab: Company Overview
Table 465 Patient-derived Xenografts (Pdx) Models Market: Impact Analysis
Table 466 Patient-derived Xenografts (Pdx) Models Market: Risk Analysis
Figures List
Figure 1 Blood Glucose Monitor Market Segmentation & Regional Scope
Figure 2 Years Considered
Figure 3 Blood Glucose Monitor Market: Research Design
Figure 4 Blood Glucose Monitor Market: Key Data From Secondary Sources
Figure 5 Blood Glucose Monitor Market: Key Primary Sources
(Demand And Supply Side)
Figure 6 Blood Glucose Monitor Market: Key Industry Insights
Figure 7 Breakdown Of Primary Interviews: Supply-side And Demand-side Participants
Figure 8 Breakdown Of Primary Interviews (Supply Side): By Company Type, Designation, And Region
Figure 9 Blood Glucose Monitor Market Size Estimation
Figure 10 Revenue Share Analysis Illustration: Medtronic Plc
Figure 11 Blood Glucose Monitor Market: Revenue Analysis Of Top 5 Companies (2024)
Figure 12 Blood Glucose Monitor Market: Epidemic Model Analysis
Figure 13 Blood Glucose Monitor Market: Top-down Approach
Figure 14 Blood Glucose Monitormarket: Cagr Projections (Supply Side) (2024)
Figure 15 Cagr Projections From Analysis Of Drivers, Restraints, Opportunities, And Challenges Of Blood Glucose Monitor Market (2025–2030)
Figure 16 Blood Glucose Monitor Market: Data Triangulation
Figure 17 Blood Glucose Monitor Market, By Product Type,
2025 Vs. 2030 (Usd Million)
Figure 18 Blood Glucose Monitor Market, By Application,
2025 Vs. 2030 (Usd Million)
Figure 19 Blood Glucose Monitor Market, By Test Site,
2025 Vs. 2030 (Usd Million)
Figure 20 Blood Glucose Monitor Market, By End User,
2025 Vs. 2030 (Usd Million)
Figure 21 Geographical Snapshot Of Blood Glucose Monitor Market
Figure 22 Increasing Technological Advancements In Blood Glucose Monitor Market To Drive Growth
Figure 23 China Accounted For Largest Share Of Asia Pacific Market In 2024
Figure 24 China To Register Highest Cagr During Forecast Period
Figure 25 Asia Pacific To Register Highest Growth Rate During Forecast Period (2025–2030)
Figure 26 Developing Markets To Register Higher Growth Rates During Forecast Period
Figure 27 Blood Glucose Monitor Market: Drivers, Restraints, Opportunities, And Challenges
Figure 28 Healthcare Expenditure As Percentage Of Gdp For
1995, 2005, 2014, And 2024
Figure 29 Blood Glucose Monitor Market: Porter’s Five Forces Analysis
Figure 30 Blood Glucose Monitor Market: Supply Chain Analysis
Figure 31 Blood Glucose Monitor Market: Value Chain Analysis
Figure 32 Blood Glucose Monitor Market: Ecosystem Analysis
Figure 33 Blood Glucose Monitor Market: Trends/Disruptions Impacting Customers’ Businesses
Figure 34 Blood Glucose Monitor Market: Funding And Number Of Deals,
2021–2024
Figure 35 Top Patent Applicants And Owners (Companies/Institutes) For Blood Glucose Monitors (January 2015–april 2025)
Figure 36 Jurisdiction Analysis: Top Applicant Countries For Blood Glucose Monitor Patents, 2015–2025
Figure 37 Key Features Of Ai/Generative Ai In Blood Glucose Monitor Market
Figure 38 Influence Of Key Stakeholders On Buying Process For Top Three Applications
Figure 39 Key Buying Criteria For Top Three Applications
Figure 40 Blood Glucose Monitor Market: Geographic Snapshot
Figure 41 North America: Blood Glucose Monitor Market Snapshot
Figure 42 Asia Pacific: Blood Glucose Monitor Market Snapshot
Figure 43 Revenue Analysis Of Key Players In Blood Glucose Monitor Market, 2020–2024
Figure 44 Market Share Analysis Of Key Players In Blood Glucose Monitor Market (2024)
Figure 45 Blood Glucose Monitor Market: Company Evaluation Matrix
(Key Players), 2024
Figure 46 Blood Glucose Monitor Market: Company Footprint
Figure 47 Blood Glucose Monitor Market: Company Evaluation Matrix (Startups/Smes), 2024
Figure 48 Ev/Ebitda Of Key Vendors
Figure 49 Year-to-date (Ytd) Price Total Return And 5-year Stock Beta Of
Key Vendors
Figure 50 Blood Glucose Monitor Market: Brand/Product Comparative Analysis
Figure 51 R&D Expenditure Of Key Players In Blood Glucose Monitor Market, 2022–2024
Figure 52 Abbott Laboratories: Company Snapshot (2024)
Figure 53 Dexcom, Inc.: Company Snapshot (2024)
Figure 54 Medtronic: Company Snapshot (2024)
Figure 55 Sinocare: Company Snapshot (2024)
Figure 56 F. Hoffmann-la Roche Ltd.: Company Snapshot (2024)
Figure 57 B. Braun Se: Company Snapshot (2024)
Figure 58 I-sens, Inc: Company Snapshot (2024)
Figure 59 Senseonics: Company Snapshot (2024)
Figure 60 Nipro: Company Snapshot (2024)
Figure 61 Terumo Corporation: Company Snapshot (2024)

Table of Contents

302 Pages
1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered & Regional Scope
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.4 Currency
1.5 Stakeholders
1.6 Summary Of Changes
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Sources Of Secondary Data
2.1.1.2 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Primary Sources
2.1.2.2 Objectives Of Primary Research
2.1.2.3 Key Industry Insights
2.1.2.4 Breakdown Of Primaries
2.2 Market Size Estimation
2.2.1 Top-down Approach (Based On Utilization Rate And Adoption Pattern)
2.3 Data Triangulation
2.4 Research Limitations
2.4.1 Scope-related Limitations
2.4.2 Methodology-related Limitations
2.5 Risk Assessment
3 Executive Summary
4 Premium Insights
4.1 Blood Glucose Monitor Market Overview
4.2 Asia Pacific: Blood Glucose Monitor Market, By Product Type And Country (2024)
4.3 Blood Glucose Monitor Market: Geographical Mix
4.4 Blood Glucose Monitor Market: Regional Mix (2025–2030)
4.5 Blood Glucose Monitor Market: Developed Vs. Developing Markets
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Prevalence Of Diabetes
5.2.1.2 Growing Elderly Population And Increasing Life Expectancy
5.2.1.3 Rise In R&D Investments And Launch Of Technologically Advanced Products
5.2.1.4 Wellness & Preventive Use Of Cgms Beyond Diabetes
5.2.2 Restraints
5.2.2.1 High Cost And Socioeconomic Disparities In Access To Blood Glucose Sensors
5.2.2.2 Short Sensor Lifespan And Frequent Replacements
5.2.3 Opportunities
5.2.3.1 Integration With Digital Health Platforms And Smart Devices
5.2.4 Challenges
5.2.4.1 Regulatory And Compliance Challenges For Non-invasive Glucose Monitoring Technologies
5.2.4.2 Data Overload & Alarm Fatigue
5.2.4.3 Financial Burden And Coverage Gaps
5.3 Unmet Needs & White Spaces
5.3.1 Unmet Needs In Blood Glucose Monitor Market
5.3.2 White Space Opportunities
5.4 Interconnected Markets & Cross-sector Opportunities
5.4.1 Interconnected Markets
5.4.2 Cross-sector Opportunities
6 Industry Trends
6.1 Porter’s Five Forces Analysis
6.1.1 Threat Of New Entrants
6.1.2 Intensity Of Competitive Rivalry
6.1.3 Bargaining Power Of Buyers
6.1.4 Bargaining Power Of Suppliers
6.1.5 Threat Of Substitutes
6.2 Macroeconomic Outlook
6.2.1 Introduction
6.2.2 Gdp Trends And Forecast
6.2.3 Trends In Diabetes Care Industry
6.2.4 Trends In Global Insulin Delivery Systems Industry
6.3 Supply Chain Analysis
6.4 Value Chain Analysis
6.5 Ecosystem Analysis
6.5.1 Role In Ecosystem
6.6 Pricing Analysis
6.6.1 Average Selling Price Of Blood Glucose Monitors, By Product, 2024
6.6.2 Average Selling Price Trend Of Self-monitoring Blood Glucose Systems, By Region, 2022–2024
6.6.3 Product Purchase Cycle, By Product Segment
6.7 Trade Analysis
6.7.1 Import Data For Hs Code 9027, 2020–2024
6.7.2 Export Data For Hs Code 9027, 2020–2024
6.8 Key Conferences & Events, 2025–2026
6.9 Trends/Disruptions Impacting Customers’ Businesses
6.10 Investment & Funding Scenario
6.11 Case Study Analysis
6.11.1 Case Study 1: Long-term Glucose Monitoring For Sensitive Skin Patients Using Senseonics’ Eversense E3 Implantable Sensor
6.11.2 Case Study 2: Enhancing Patient Adherence And Glycemic Control Using Abbott’s Freestyle Libre 2 Cgm
6.11.3 Case Study 3: Improving Glycemic Control With Dexcom G6 Cgm System
6.12 Impact Of 2025 Us Tariffs On Blood Glucose Monitor Market
6.12.1 Introduction
6.12.2 Key Tariff Rates
6.12.3 Price Impact Analysis
6.12.4 Impact On Region
6.12.4.1 Us
6.12.4.2 Europe
6.12.4.3 Asia Pacific
6.12.5 Impact On End-use Industries
7 Strategic Disruptions Through Technology, Patents, And Digital And Ai Adoption
7.1 Key Emerging Technologies
7.2 Complementary Technologies
7.2.1 Battery And Energy Harvesting Innovations
7.3 Technology/Product Roadmap
7.3.1 Short Term (2025–2027) | Foundation & Early Commercialization
7.3.2 Mid Term (2027–2030) | Expansion & Standardization
7.3.3 Long Term (2030–2035+) | Mass Commercialization & Disruption
7.4 Patent Analysis
7.4.1 Patent Publication Trends For Blood Glucose Monitor Market
7.4.2 Top Applicants (Companies) Of Blood Glucose Monitor Patents
7.4.3 Jurisdiction Analysis: Top Applicants (Countries) For Patents In Blood Glucose Monitor Market
7.4.4 List Of Major Patents
7.5 Pipeline Analysis
7.6 Impact Of Ai/Gen Ai On Blood Glucose Monitor Market
7.6.1 Top Use Cases And Market Potential
7.6.2 Top Case Studies Of Ai Implementation In Blood Glucose Monitor Market
7.6.3 Interconnected Adjacent Ecosystems And Impact On Market Players
7.6.4 Clients’ Readiness To Adopt Generative Ai In Blood Glucose Monitor Market
7.7 Success Stories & Real-world Applications
7.7.1 Abbott: Freestyle Libre 3—miniaturized Sensor With Real-time Connectivity
7.7.2 Dexcom: G7 Sensor—advanced Algorithm For Accurate And Fast Glucose Readings
7.7.3 Senseonics: Eversense E3—long-term Implantable Cgm With Smart Alerts
8 Treatment & Regulatory Landscape
8.1 Regional Regulations & Compliance
8.1.1 Regulatory Bodies, Government Agencies, And Other Organizations
8.1.2 Regulatory Standards
8.1.2.1 North America
8.1.2.1.1 Us
8.1.2.1.2 Canada
8.1.2.2 Europe
8.1.2.3 Asia Pacific
8.1.2.3.1 China
8.1.2.3.2 Japan
8.1.2.3.3 India
8.1.2.4 Latin America
8.1.2.4.1 Brazil
8.1.2.4.2 Mexico
8.1.2.5 Middle East
8.1.2.6 Africa
8.2 Epidemiology Of Diabetes, By Key Country
8.3 Certifications, Labeling, And Eco-standards
8.3.1 Certifications, Labeling, And Eco-standards In Blood Glucose Monitor Market
8.4 Treatment And Regulatory Landscape
8.4.1 Sustainability Impact And Regulatory Policy Initiatives
 
9 Customer Landscape & Buyer Behavior
9.1 Decision-making Process
9.2 Key Stakeholders & Buying Criteria
9.2.1 Key Stakeholders In Buying Process
9.2.2 Key Buying Criteria
9.3 Adoption Barriers & Internal Challenges
9.4 Unmet Needs Of End Users
9.5 Market Profitability
9.5.1 Revenue Potential
9.5.2 Cost Dynamics
9.5.3 Margin Opportunities In Key Applications
10 Blood Glucose Monitor Market, By Product Type
10.1 Introduction
10.2 Self-monitoring Blood Glucose Systems
10.2.1 Glucometers
10.2.1.1 Regulatory Reinforcement And Digital Integration To Drive Advancements In Market
10.2.2 Testing Strips
10.2.2.1 Shift Toward Non-invasive Methods For Blood Glucose Monitoring To Restrain Market Growth
10.2.3 Lancets & Lancing Devices
10.2.3.1 Rising Focus On Reducing Chances Of Infection To Increase Popularity Of Safety Lancets
10.3 Continuous Glucose Monitoring Systems
10.3.1 Sensors
10.3.1.1 Technological Advancements And Expanding Use In Diabetes Management To Boost Market Growth
10.3.2 Implants
10.3.2.1 Rising Demand For Long-duration Sensors Offering Extended Lifespan And Reduced Replacement Frequency To Drive Growth
10.3.3 Transmitters & Receivers
10.3.3.1 Integration With Smart Monitoring Systems And Interoperable Diabetes Management Platforms To Fuel Growth
10.4 Professional Point-of-care Devices
10.4.1 Advancing Patient Care Through Decentralized Point-of-care Glucose Monitoring To Boost Market
10.5 Non-invasive Products
10.5.1 Rising Patient Preference For Painless Technology To Foster Development And Adoption In Future
 
11 Blood Glucose Monitor Market, By Test Site
11.1 Introduction
11.2 Fingertip
11.2.1 High Accuracy Associated With Fingertip Testing To Support Market Growth
11.3 Upper Arm
11.3.1 Rise Of Continuous And Minimally Invasive Monitoring Technologies To Boost Demand For Upper Arm Testing
11.4 Other Test Sites
12 Blood Glucose Monitor Market, By Application
12.1 Introduction
12.2 Diabetes Management
12.2.1 Type 1 Diabetes
12.2.1.1 Intensive Management Needs Associated With Type 1 Diabetes To Boost Adoption
12.2.2 Type 2 Diabetes
12.2.2.1 High Prevalence Of Type 2 Diabetes To Drive Market Demand
12.3 Health & Wellness Monitoring
12.3.1 Emerging Role Of Health & Wellness Monitoring For Blood Glucose Monitors To Drive Market Growth
12.4 Other Applications
13 Blood Glucose Monitor Market, By End User
13.1 Introduction
13.2 Self/Home Care
13.2.1 Convenient, Cost-effective, And Frequent Monitoring Associated With Home Care Settings To Drive Market
13.3 Hospitals & Clinics
13.3.1 Strategic Adoption Of Blood Glucose Sensors In Hospitals & Clinics To Drive Market Validation And Growth
13.4 Other End Users
14 Blood Glucose Monitor Market, By Region
14.1 Introduction
14.2 North America
14.2.1 Macroeconomic Outlook For North America
14.2.2 Us
14.2.2.1 Us To Account For Largest Share Of North American Blood Glucose Monitor Market
14.2.3 Canada
14.2.3.1 Rising Government Support To Boost Blood Glucose Monitor Market In Canada
 
14.3 Europe
14.3.1 Macroeconomic Outlook For Europe
14.3.2 Germany
14.3.2.1 Germany To Dominate European Blood Glucose Monitor Market
14.3.3 Uk
14.3.3.1 Government Support And Research Funding To Drive Blood Glucose Monitor Market Growth In Uk
14.3.4 France
14.3.4.1 High Insurance Coverage And Increasing Affordability To Support Market Growth
14.3.5 Italy
14.3.5.1 Increasing Government Spending To Drive Market Growth In Italy
14.3.6 Spain
14.3.6.1 High Diabetes Prevalence To Drive Market Growth In Spain
14.3.7 Rest Of Europe (Roe)
14.4 Asia Pacific
14.4.1 Macroeconomic Outlook For Asia Pacific
14.4.2 China
14.4.2.1 China To Dominate Asia Pacific Blood Glucose Monitor Market
14.4.3 Japan
14.4.3.1 Rising Aging Population And High Number Of Diabetes Cases To Drive Market Growth In Japan
14.4.4 India
14.4.4.1 Rising Diabetes Cases And Affordable Local Manufacturing To Fuel Insulin Device Demand In India
14.4.5 Australia
14.4.5.1 Government Subsidies To Drive Market
14.4.6 South Korea
14.4.6.1 Rising Diabetes Cases Across Country To Boost Market
14.4.7 Rest Of Asia Pacific
14.5 Latin America
14.5.1 Macroeconomic Outlook For Latin America
14.5.2 Brazil
14.5.2.1 Brazil To Account For Largest Share Of Latin American Blood Glucose Monitor Market
14.5.3 Mexico
14.5.3.1 Rising Diabetes Prevalence To Drive Market Growth
14.5.4 Rest Of Latin America
14.6 Middle East & Africa
14.6.1 International Aid Programs And Government-led Initiatives For Non-communicable Disease Management To Foster Growth
14.6.2 Macroeconomic Outlook For Middle East & Africa
 
14.7 Gcc Countries
14.7.1 Rising Diabetes Prevalence To Drive Market In Gcc Countries
14.7.2 Macroeconomic Outlook For Gcc Countries
15 Competitive Landscape
15.1 Introduction
15.2 Key Player Strategies/Right To Win
15.2.1 Overview Of Strategies Adopted By Players In Blood Glucose Monitor Market
15.3 Revenue Analysis, 2020–2024
15.4 Market Share Analysis, 2024
15.5 Company Evaluation Matrix: Key Players, 2024
15.5.1 Stars
15.5.2 Emerging Leaders
15.5.3 Pervasive Players
15.5.4 Participants
15.5.5 Company Footprint: Key Players, 2024
15.5.5.1 Company Footprint
15.5.5.2 Region Footprint
15.5.5.3 Product Type Footprint
15.5.5.4 Test Site Footprint
15.5.5.5 Application Footprint
15.6 Company Evaluation Matrix: Startups/Smes, 2024
15.6.1 Progressive Companies
15.6.2 Responsive Companies
15.6.3 Dynamic Companies
15.6.4 Starting Blocks
15.6.5 Competitive Benchmarking: Startups/Smes, 2024
15.6.5.1 Detailed List Of Key Startups/Smes
15.6.5.2 Competitive Benchmarking Of Key Startups/Smes
15.7 Company Valuation & Financial Metrics
15.7.1 Financial Metrics
15.7.2 Company Valuation
15.8 Brand/Product Comparison
15.9 R&D Expenditure Of Key Players
15.10 Competitive Scenario
15.10.1 Product Launches & Approvals
15.10.2 Deals
15.10.3 Expansions
15.10.4 Other Developments
 
16 Company Profiles
16.1 Key Players
16.1.1 Abbott Laboratories
16.1.1.1 Business Overview
16.1.1.2 Products Offered
16.1.1.3 Recent Developments
16.1.1.3.1 Product Launches & Approvals
16.1.1.3.2 Deals
16.1.1.3.3 Expansions
16.1.1.3.4 Other Developments
16.1.1.4 Mnm View
16.1.1.4.1 Right To Win
16.1.1.4.2 Strategic Choices
16.1.1.4.3 Weaknesses & Competitive Threats
16.1.2 Dexcom, Inc.
16.1.2.1 Business Overview
16.1.2.2 Products Offered
16.1.2.3 Recent Developments
16.1.2.3.1 Product Launches & Approvals
16.1.2.3.2 Deals
16.1.2.4 Mnm View
16.1.2.4.1 Right To Win
16.1.2.4.2 Strategic Choices
16.1.2.4.3 Weaknesses & Competitive Threats
16.1.3 Medtronic
16.1.3.1 Business Overview
16.1.3.2 Products Offered
16.1.3.3 Recent Developments
16.1.3.3.1 Product Approvals
16.1.3.3.2 Deals
16.1.3.3.3 Expansions
16.1.3.3.4 Other Developments
16.1.3.4 Mnm View
16.1.3.4.1 Right To Win
16.1.3.4.2 Strategic Choices
16.1.3.4.3 Weaknesses & Competitive Threats
16.1.4 Sinocare
16.1.4.1 Business Overview
16.1.4.2 Products Offered
16.1.4.3 Recent Developments
16.1.4.3.1 Product Approvals
16.1.4.3.2 Deals
16.1.4.3.3 Other Developments
16.1.4.4 Mnm View
16.1.4.4.1 Right To Win
16.1.4.4.2 Strategic Choices
16.1.4.4.3 Weaknesses & Competitive Threats
16.1.5 Roche Diabetes Care
16.1.5.1 Business Overview
16.1.5.2 Products Offered
16.1.5.3 Recent Developments
16.1.5.3.1 Product Launches & Approvals
16.1.5.3.2 Expansions
16.1.5.4 Mnm View
16.1.5.4.1 Right To Win
16.1.5.4.2 Strategic Choices
16.1.5.4.3 Weaknesses & Competitive Threats
16.1.6 B. Braun Se
16.1.6.1 Business Overview
16.1.6.2 Products Offered
16.1.7 I-sens, Inc.
16.1.7.1 Business Overview
16.1.7.2 Products Offered
16.1.7.3 Recent Developments
16.1.7.3.1 Product Approvals
16.1.7.3.2 Deals
16.1.8 Senseonics
16.1.8.1 Business Overview
16.1.8.2 Products Offered
16.1.8.3 Recent Developments
16.1.8.3.1 Product Launches & Approvals
16.1.8.3.2 Deals
16.1.8.3.3 Other Developments
16.1.9 Ascensia Diabetes Care Holdings Ag
16.1.9.1 Business Overview
16.1.9.2 Products Offered
16.1.9.3 Recent Developments
16.1.9.3.1 Product Launches
16.1.9.3.2 Deals
16.1.10 Nipro
16.1.10.1 Business Overview
16.1.10.2 Products Offered
16.1.10.3 Recent Developments
16.1.10.3.1 Expansions
16.1.11 Nemaura Medical Inc.
16.1.11.1 Business Overview
16.1.11.2 Products Offered
16.1.11.3 Recent Developments
16.1.11.3.1 Other Developments
16.1.12 Medical Technology And Devices S.P.A.
16.1.12.1 Business Overview
16.1.12.2 Products Offered
16.1.12.3 Recent Developments
16.1.12.3.1 Deals
16.1.13 Terumo Corporation
16.1.13.1 Business Overview
16.1.13.2 Products Offered
16.1.13.3 Recent Developments
16.1.13.3.1 Deals
16.1.13.3.2 Expansions
16.1.13.3.3 Other Developments
16.1.14 Lifescan Ip Holdings, Llc
16.1.14.1 Business Overview
16.1.14.2 Products Offered
16.1.14.3 Recent Developments
16.1.14.3.1 Deals
16.2 Other Players
16.2.1 Acon Laboratories, Inc.
16.2.2 Lifeplus
16.2.3 Prodigy Diabetes Care, Llc
16.2.4 Ultrahuman Healthcare Pvt. Ltd.
16.2.5 Beurer Gmbh
16.2.6 Oura Health Oy
16.2.7 Sd Biosensor, Inc.
16.2.8 A. Menarini Diagnostics S.R.L
16.2.9 Medisana Gmbh
16.2.10 Agatsa
16.2.11 Rossmax International Ltd.
17 Appendix
17.1 Discussion Guide
17.2 Knowledgestore: Marketsandmarkets’ Subscription Portal
17.3 Customization Options
17.4 Related Reports
17.5 Author Details

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us